@adamfeuerstein @AmyDBMine @AfrezzaArmy I would appreciate if I would be left out of these kinds of discussion.This does not help diabetics
1 retweet 6 favorites
afrezzauser @afrezzauser 58m58 minutes ago
@adamfeuerstein @AmyDBMine @AfrezzaArmy in the world as a mealtime insulin.Proven by many.I have no financial interest in Mannkind or Sanofi
0 retweets 2 favorites
afrezzauser @afrezzauser 59m59 minutes ago
@adamfeuerstein @AmyDBMine @AfrezzaArmy No time or energy here for pointless tiffs, posturing, and propaganda. Nothing compares to #afrezza
"Afrezza represents a promising noninjectable insulin delivery option for type 1 and type 2 diabetes mellitus. According to clinical trial evidence, it appears to be efficacious and comparable to currently available prandial insulin options, and based on current data, it appears to be a safe alternative to injectable insulin with high treatment satisfaction."
All in all, not bad!
1. we get our 9M shares back from BOA, SO they CANNOT be SHORTED!
2. We issue 9M+possibly a max of 3M shares - SO THEY CANNOT BE SHORTED. BOA (or whoever becomes A LONG)
3. dilution - Max 3M shares
4. BALANCE SHEET - Much BETTER!
5. IF PRICE GOES UP in 10 days less shares issued
6. Filing 1 day before SANOFI REPORTS
me thinks they are expecting PRICE to JUMP!
So it doesn't work for her, so she's bipolar, so we don't get a sale!,
By constantly questioning this woman, we are buying into her little TRAP!
I suspect she's a hired gun disguised as a patient who "tried" it
Please FOCUS on the positive. If you don't egg her on or question her, she WILL GO AWAY!
Today is going to be a good day!
As many have noticed, (and thank you all), Endo's are posting Afrezza posters, local news channels are picking up stories of the "inhalable insulin" and the DTC campaign is beginning! BUT MOST importantly - Diabetics are appreciating and loving the product!
Personally I think we are now at the cusp of a major turnaround.
(930 AM EST) Webcast available.
● New data from the AFFINITY 1 study
~ No increase in hypoglycemia risk resulting from a
supplemental dose of Afrezza® 90 min post-meal(1)
(1) Blonde et al, AACE 2015, Late breaking abstract
My humble advice is:
Don't you DARE sell a SINGLE SHARE of MANNKIND!!
Did i say this before?
THEY WILL STEAL YOUR SHARES!!!!!
frankly I don't think Sam is paid, and I also don't think Amy is paid. I simply think she's bipolar.
AF on the other hand is PAID
Hey shortie, guess what ??!! I can wait until 2017. Can you?
0. MOST IMPORTANT- DIABETICS LOVE IT!!
1. Matt - upped his game
2. Al-- ever present;ever gracious -Lifetime award -with Sanofi on one side, Medatronic on the other
3. Hakan- Flew to Paris to tell Sanofi- Lets go!
4. Triple production
5. Jeffries -PT $37 in 2017
6. Griffin - PT 16.25
7. GS- downgrade to $2 -BUY signal
8. Krap - Sold half his PUTs- Another BUY SIGNAL
9. BOA - Call purchases
10- Martin what's his name - IDwhateverOIT!
11. -FDA -Competition oral drugs cause ketoacidosis
12 ARAB TV
13. No Dilution for BOA notes- Borrow from AL.- (Al ends up owning more of the company)
14 Any--- questions?????!!!!!!
so they end up on the street the GREEDY TARDS; I will be satisfied. Not about my profits anymore. It's about helping Diabetics!
I'll consider it charity
no I don't think so. These numbers include the two 10% gain days last week; which they tried to short more so that the pps wouldn't rise from the $3.5-$4s
One little spark and this think will skyrocket to over $20 if the LONGS hold strong!